Caris Life Sciences, Inc.
NASDAQ: CAI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Dean Halbert
- Employees
- 1,769
- Headquarters
- Irving, United States
- IPO year
- 2025
- Market cap
- $5.2B
- Website
- https://www.carislifesciences.com
Loading CAI…
Loading profile data…Frequently asked questions about CAI
What does Caris Life Sciences, Inc. (CAI) do?
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular da...
Where does CAI trade?
Caris Life Sciences, Inc. (CAI) trades on the NASDAQ Global Select.
What sector is CAI in?
Caris Life Sciences, Inc. (CAI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Caris Life Sciences, Inc.?
David Dean Halbert is the chief executive officer of Caris Life Sciences, Inc. (CAI).
Where is Caris Life Sciences, Inc. headquartered?
Caris Life Sciences, Inc. is headquartered in United States.
Does CAI pay a dividend?
Caris Life Sciences, Inc. (CAI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CAI go public?
Caris Life Sciences, Inc. (CAI) completed its initial public offering in 2025.